Danaher Co. (NYSE:DHR) Shares Purchased by Jump Financial LLC

Jump Financial LLC raised its holdings in Danaher Co. (NYSE:DHR - Free Report) by 504.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 57,941 shares of the conglomerate's stock after buying an additional 48,350 shares during the period. Jump Financial LLC's holdings in Danaher were worth $13,300,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of DHR. Heck Capital Advisors LLC acquired a new position in shares of Danaher during the fourth quarter worth about $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher during the 4th quarter worth approximately $31,000. Golden State Wealth Management LLC purchased a new stake in shares of Danaher in the 4th quarter valued at approximately $31,000. Strategic Financial Concepts LLC acquired a new stake in shares of Danaher in the 4th quarter valued at $31,000. Finally, Pineridge Advisors LLC lifted its position in shares of Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock worth $34,000 after purchasing an additional 57 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of NYSE:DHR traded down $3.95 during midday trading on Friday, hitting $186.71. The stock had a trading volume of 3,667,685 shares, compared to its average volume of 3,329,253. The company has a market capitalization of $133.44 billion, a PE ratio of 35.36, a P/E/G ratio of 2.66 and a beta of 0.86. The stock has a 50 day moving average price of $201.99 and a two-hundred day moving average price of $226.91. Danaher Co. has a 1 year low of $171.00 and a 1 year high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the business earned $2.09 earnings per share. As a group, equities analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.32 dividend. This is an increase from Danaher's previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.69%. The ex-dividend date is Friday, March 28th. Danaher's dividend payout ratio (DPR) is presently 24.24%.

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 5,700 shares of the business's stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 11.10% of the stock is currently owned by insiders.

Analyst Ratings Changes

DHR has been the topic of a number of analyst reports. Robert W. Baird set a $231.00 price target on Danaher in a research note on Wednesday. Wells Fargo & Company decreased their target price on Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a research note on Thursday, January 30th. Royal Bank of Canada reiterated an "outperform" rating and issued a $277.00 price target (down from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Barclays upgraded shares of Danaher from an "equal weight" rating to an "overweight" rating and reduced their price objective for the stock from $240.00 to $205.00 in a research report on Thursday, April 10th. Finally, Stifel Nicolaus raised shares of Danaher from a "hold" rating to a "buy" rating and set a $260.00 target price on the stock in a research report on Friday, March 14th. Four research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $274.55.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.